• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Press releases

New Collection from PLoS and DNDi highlights a decade of R&D into neglected tropical diseases

Cambridge, UK — 27 Nov 2013

As part of a collaborative initiative, PLoS and the Drugs for Neglected Diseases initiative (DNDi) are delighted to be launching a special Collection—PLoS & DNDi: a decade of Open Access and Neglected Tropical Diseases R&D (Research and Development)—to coincide with a joint event at the Institut Pasteur in Paris celebrating the 10-year anniversary of DNDi.

In addition to being the same age, PLoS and DNDi have much in common. Both organisations have broken convention, both have pushed boundaries, and both have successfully combined the pursuit of quality scientific research and its publication with strong advocacy.

The Collection showcases the best of Open Access R&D for neglected tropical diseases (NTDs). The 21 articles in the Collection from across the PLoS journals highlight the journey over the past decade from advocacy, new innovations and partnerships, to the scientific research of new drugs.

For example, a Collection article on Chagas disease discusses how the poorest people living in the Mexico and the U.S. are still silently suffering under the heavy burden of this infection. Another shows that although estimated to cause the ninth largest disease burden among individual infectious diseases, leishmaniasis is largely ignored in discussions of tropical disease priorities. And the Collection also highlights human African trypanosomiasis, fatal if left untreated, afflicting sub-Saharan Africa despite being nearly eliminated in the past.

“We must take this opportunity to reflect on our 10 years of experience and look at how open models are serving the greater public health good, especially for those who need it most”, says Dr Bernard Pécoul, Executive Director of DNDi. “DNDi and PLoS are both experiments from which many important lessons can be learned to guide future directions in research.”

Rhona MacDonald, Senior Editor at PLoS Medicine says: “We hope that in addition to celebrating and commemorating the past ten years of research and development for neglected tropical diseases, the Collection will inspire action and galvanise scientists, the pharmaceutical industry and the wider international community to find tangible solutions.”

###

Upon launch, please visit the Collection at: http://www.ploscollections.org/dndi
Link will go live when the Collection launches on December 4th 2013 9am Pacific Time

Contact: Press Office
collections@plos.org
Public Library of Science

This press release was written and issued by PLoS on 27 November 2013.

Chagas disease Filaria: river blindness Paediatric HIV Visceral leishmaniasis

Read, watch, share

Loading...
Jessica Robbins
Stories
24 Oct 2025

Jessica Robbins: A long and difficult journey with cutaneous leishmaniasis

Videos
24 Oct 2025

Road to Elimination of Kala-azar in South Asia

Videos
22 Oct 2025

The Boy Who Beat the Sandfly

Viewpoints
9 Oct 2025

Pharma’s shift away from infectious disease research could spell disaster for the world’s poorest people

STAT
News
3 Oct 2025

DNDi 2025 Projects of the Year recognize contributions of DNDi teams and partners working to deliver urgently needed innovations for people affected by Chagas disease and river blindness

Nature Africa logo
Viewpoints
30 Sep 2025

Drug development for neglected diseases must account for kids

Nature Africa
Press releases
23 Sep 2025

Open-science approach delivers a promising pre-clinical candidate for broad-spectrum coronavirus antiviral 

Publications
2 Sep 2025

DNDi Brochure

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license